Skip to main navigation
Skip to search
Skip to main content
University of Edinburgh Research Explorer Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Datasets
Prizes
Activities
Press/Media
Equipment
Search by expertise, name or affiliation
MS-STAT2: A phase 3 randomised, double blind, clinical trial investigating the effectiveness of repurposed simvastatin compared to placebo in secondary progressive multiple sclerosis, in slowing the progression of disability
Chandran, Siddharthan
(Principal Investigator)
Connick, Peter
(Co-investigator)
Deanery of Clinical Sciences
Edinburgh Imaging
Anne Rowling Regenerative Neurology Clinic
University of Edinburgh
Overview
Project Details
Status
Finished
Effective start/end date
1/03/17
→
31/08/23
Funding
Other:
£78,785.00
View all
View less